NCT05007314 is a NA clinical trial of Biocriminological Evidence in Criminalism, sponsored by Leiden University Medical Center.

Who is sponsoring NCT05007314?

NCT05007314 is sponsored by Leiden University Medical Center.

What drugs are being tested in NCT05007314?

Interventions in NCT05007314: Biocriminological Evidence.

What condition does NCT05007314 study?

NCT05007314 studies Criminalism.

Is NCT05007314 still recruiting?

NCT05007314 is currently completed. Last updated 16 August 2022.

Last reviewed 2022-08-16 · How we verify

NCT05007314

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biocriminology and the Adjudication of Criminal Responsibility: Is There a Consensus Among Scientists' Verdicts?

Completed NA Last updated 16 August 2022

What this trial tests

NA trial testing Biocriminological Evidence in Criminalism in 160 participants. Completed in 1 July 2022.

Timeline

1 July 2021

Primary endpoint
1 July 2022

1 July 2022

Quick facts

Lead sponsor	Leiden University Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	basic science
Enrollment	160
Start date	1 July 2021
Primary completion	1 July 2022
Estimated completion	1 July 2022
Sites	1 location across Netherlands

Drugs / interventions tested

Biocriminological Evidence

Conditions studied

Criminalism — all drugs for Criminalism →

Sponsor

Leiden University Medical Center

Who can join

Adults 18 to 65, any sex, with Criminalism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Because of the evolving nature of psychology research, non-scientists are more likely to struggle or misinterpret evidence regarding a person's psychological state. Misconceptions may thus be highly prevalent within the justice system, leading to negative consequences for people with psychological or neurobiological disorders. At the same time, no research has been conducted to compare the punishment perspectives of non-scientists, that typically make sentencing decisions, to scientists who possess a more advanced understanding of human biology and behavior.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Leiden University Medical Center trials

Trials by the same sponsor.

NCT07312565 — Occurrence of Abdominal Aortic Aneurysms in Patients With Aneurysmal Subarachnoid Hemorrhage · not yet recruiting
NCT07090343 — Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement · Phase 3 · not yet recruiting
NCT07498738 — Making Diabetes Care Fit for Young Adults Living With Type 1 Diabetes: Observations, Reflections and Expert Opinions · NA · not yet recruiting
NCT06545292 — Microsampling for Therapeutic Drug Monitoring of Oral Oncolytics in Oncology Patients · NA · recruiting
NCT07021495 — SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05007314 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Leiden University Medical Center
Last refreshed: 16 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05007314.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing